NeuroRehabilitation + TES for Cognitive Disorders
(PCN Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores methods to enhance thinking skills that may decline due to aging or diseases like Alzheimer’s. It tests whether brain training exercises, combined with a mild electrical treatment called transcranial electrical stimulation (TES), can improve memory, attention, and problem-solving skills. Participants may receive either real or sham treatments to determine the most effective approach. Individuals aged 50 or older who have noticed issues with their thinking abilities might be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to research that could improve cognitive health for many.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that treatments like transcranial electrical stimulation (TES) are generally safe. No serious side effects have been reported for methods such as transcranial Direct Current Stimulation (tDCS) and transcranial Alternating Current Stimulation (tACS). Some individuals might experience mild skin issues from tDCS, but this is uncommon.
Studies indicate that cognitive interventions can improve daily tasks and thinking skills, particularly in older adults. These interventions are well-tolerated, with most participants experiencing no major problems.
In summary, both TES and cognitive interventions have demonstrated safety and are usually well-tolerated by participants.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for cognitive disorders because they leverage transcranial electrical stimulation (TES) techniques like tDCS, tACS, and tRNS to potentially enhance brain function. Unlike traditional methods that rely heavily on medication or behavioral therapy, these TES methods use non-invasive electrical currents to stimulate specific brain areas, promising a more direct impact on neural activity. Additionally, the combination of TES with cognitively based interventions could offer a synergistic effect, possibly accelerating cognitive improvements. This dual approach aims to provide a more comprehensive and personalized treatment strategy, addressing the limitations of current standard options.
What evidence suggests that this trial's treatments could be effective for improving cognitive abilities?
Studies have shown that transcranial electrical stimulation (TES), which participants in this trial may receive, can improve thinking skills in some older adults, particularly those with mild memory problems. However, results can vary, and improvements in memory or decision-making are not always noticeable. In contrast, activities focusing on thinking skills, such as cognitive rehabilitation, offer another treatment option in this trial. These activities often help people manage daily tasks better and slow mental decline. Research suggests they can enhance language skills and memory. This trial will also explore combining TES with cognitive rehabilitation, which might amplify these benefits, though results can differ for each person.678910
Who Is on the Research Team?
Benjamin M Hampstead, Ph.D.
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for individuals aged 50 or older who have noticed a decline in their cognitive abilities. It's open to those with and without diagnosed cognitive issues. People can't join if they have serious mental illnesses, are pregnant, might become pregnant, have metal/electronic implants in the head, history of substance abuse, or sensory/motor impairments that would limit participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive transcranial electrical stimulation (TES) and/or cognitively based interventions tailored to individual needs, potentially including up to 260 sessions of TES
Follow-up
Participants are monitored for cognitive changes and symptomatic changes through neuropsychological testing and questionnaires
Long-term follow-up
Participants undergo additional assessments such as MRS and fMRI to evaluate long-term changes
What Are the Treatments Tested in This Trial?
Interventions
- Active tACS
- Active tDCS
- Active tRNS
- Cognitively based intervention
- Sham tACS
- Sham tRNS
Active tACS is already approved in United States, European Union for the following indications:
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline
- Investigational for cognitive rehabilitation in neurodegenerative diseases and aging-related cognitive decline
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor